The estimated Net Worth of Jesse Chew is at least 1.63 百万$ dollars as of 30 November 2023. Mr Chew owns over 29,770 units of Accuray Inc stock worth over 752,382$ and over the last 6 years he sold ARAY stock worth over 258,947$. In addition, he makes 621,118$ as Sr. VP、 Gen. Counsel & Corp. Sec. at Accuray Inc.
Mr has made over 13 trades of the Accuray Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 29,770 units of ARAY stock worth 73,532$ on 30 November 2023.
The largest trade he's ever made was selling 29,770 units of Accuray Inc stock on 30 November 2023 worth over 73,532$. On average, Mr trades about 5,235 units every 109 days since 2018. As of 30 November 2023 he still owns at least 381,920 units of Accuray Inc stock.
You can see the complete history of Mr Chew stock trades at the bottom of the page.
Jesse Chew is the Sr. VP, Gen. Counsel & Corp. Sec. at Accuray Inc.
As the Sr. VP、 Gen. Counsel & Corp. Sec. of Accuray Inc, the total compensation of Mr Chew at Accuray Inc is 621,118$. There are 7 executives at Accuray Inc getting paid more, with Ali Pervaiz having the highest compensation of 5,183,662$.
Mr Chew is 40, he's been the Sr. VP、 Gen. Counsel & Corp. Sec. of Accuray Inc since . There are 14 older and 1 younger executives at Accuray Inc. The oldest executive at Accuray Inc is Elizabeth Davila, 75, who is the Independent Director.
Jesse's mailing address filed with the SEC is 1310, Chesapeake Terrace, Sunnyvale, Santa Clara County, California, 94089, United States.
Over the last 18 years, insiders at Accuray Inc have traded over 37,863,458$ worth of Accuray Inc stock and bought 806,995 units worth 5,047,672$ . The most active insiders traders include International Investment Ho...、Robert S Weiss、Euan Thomson. On average, Accuray Inc executives and independent directors trade stock every 24 days with the average trade being worth of 62,792$. The most recent stock trade was executed by Ali Pervaiz on 4 September 2024, trading 8,404 units of ARAY stock currently worth 17,312$.
accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.
Accuray Inc executives and other stock owners filed with the SEC include: